LBBAP Data Collection Registry

CompletedOBSERVATIONAL
Enrollment

221

Participants

Timeline

Start Date

April 25, 2023

Primary Completion Date

July 11, 2023

Study Completion Date

July 11, 2023

Conditions
BradycardiaSinus Node DysfunctionHeart BlockSyncopeCardiomyopathiesHeart Failure
Interventions
DEVICE

Implantation of the Tendril 2088 lead in the LBBA

Conduction system pacing is achieved by delivering a pacing stimulus to the Left Bundle Branch area of the heart with Abbott's Tendril 2088 lead.

Trial Locations (11)

13005

Hopital d'adulte de la Timone, Marseille

32501

Cardiology Consultants - Baptist Campus, Pensacola

38801

North Mississippi Medical Center, Tupelo

45100

Ospedale S.Maria della Misericordia, Rovigo

72401

Arrhythmia Research Group, Jonesboro

92270

Eisenhower Medical Center, Rancho Mirage

122001

Medanta - The Medicity Hospital, Gūrgaon

600037

The Madras Medical Mission, Chennai

17822-2150

Geisinger Medical Center, Danville

Unknown

National Heart Centre Singapore, Singapore

Tan Tock Seng Hospital, Singapore

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT05887323 - LBBAP Data Collection Registry | Biotech Hunter | Biotech Hunter